[ Price : $8.95]
Federal Register Notice: FDA withdraws an indication for GlaxoSmithKlines Bexxar because a postmarketing study that was a conditio...[ Price : $8.95]
Federal Register Notice: FDA determines that Intal Inhalation Capsule, 20 mg was not withdrawn from sale for reasons of safety or ...[ Price : $8.95]
Federal Register Notice: FDA determines that Paraflex tablets, 250 mg were not withdrawn from sale for reasons of safety or effect...[ Price : $8.95]
Federal Register Notice: FDA determines that Nova-K LLCs potassium citrate, 10 mEq/packet and 20 mEq/packet was not withdrawn for ...[ Price : $8.95]
FDA assigns a priority review for an Eli Lilly BLA for IMC-1121B (ramucirumab) as a single-agent treatment for advanced gastric ca...[ Price : $8.95]
FDA approves Allergans Juvederm Voluma XC, a dermal filler for temporarily correcting age-related volume loss in the cheek area in...[ Price : $8.95]
Federal Register Notice: FDAs Pediatric Oncology Subcommittee will meet 11/5 to the development of three products for potential pe...[ Price : $8.95]
FDA grants Merck a breakthrough therapy designation for MK-5172/MK-8742 for treating chronic hepatitis C virus infection.